France Aesthetic Medicine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The France Aesthetic Medicine Market has been segmented by Product (Botulinum Toxin, Dermal Filler, Chemical Peel, and Microdermabrasion) and End User (Aesthetic Clinics, Hospitals, and Other End Users).

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
CAGR: 8.58 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Key factors propelling the growth of the market are the growing adoption of non-invasive aesthetic procedures, increasing awareness among customers, and the availability of user-friendly aesthetic products.

In France, it has been observed that patients begin anti-aging techniques and minimally-invasive treatments at a very young age, and require more invasive procedures to maintain their youthful appearance. Moreover, the rise in disposable income has boosted the demand for cosmetic surgeries, thereby, accelerating the market growth.

Along with the increased awareness about the potential benefits of aesthetic procedures, people are also inclined toward the use of minimal or non-invasive procedures in aesthetic treatments. The popularity of non-invasive or minimally invasive techniques is increasing in France. The reason for significant inclination is that majority of the audiences perceive normal surgical treatments as painful and with high risk factors. Thus, the growing adoption of non- or minimally-invasive aesthetic procedures is fueling the growth of the French aesthetic medicine market.

Additionally, there has been an abundant rise in advertising, displaying the ‘before’ and ‘after’ difference of various aesthetic procedures, thereby, prompting the youth and middle-aged to undergo medical aesthetic procedures.

Scope of the Report

As per the scope of the report, aesthetic medicine is defined as the specialties that focus on enhancing cosmetic appearance through the treatment of aging, infectious, or diseased skin conditions. Aesthetic medicines and cosmetic surgeries are developing clinical subspecialty and field in scientific research, which comprise all kinds of medical procedures whose purpose is to improve the physical appearance of the patients, including all non-invasive and minimally-invasive cosmetic procedures.

By Product
Botulinum Toxin
Dermal Filler
Absorbable Dermal Filler
Non-absorbable Dermal Filler
Chemical Peel
By End User
Aesthetic Clinics
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Dermal Filler is Expected to Grow the Largest over the Forecast Period

  • The dermal filler segment has the largest market share, and it is expected to continue during the forecast period. It is constantly developing in France, and it accounts for a sales volume of around 850,000 dermal syringes, annually.
  • Absorbable dermal fillers are majorly contributing to the total dermal filler market segment in France, due to its minimum side effects. On the other hand, agencies in France are currently not advising the use of non-absorbable products for aesthetic purposes, given the risk of extremely delayed, uncontrollable, and serious adverse effects.
france aesthetic.png

To understand key trends, Download Sample Report

Competitive Landscape

The French aesthetic medicine market is fairly consolidated, with some local players competing with international players. Major strategies adopted by most of the key industry players include new product launches, acquisitions, mergers, and partnerships, to strengthen the aesthetics product portfolio and maintain their market positioning.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Adoption of Non- and Minimally-Invasive Aesthetic Procedures

      2. 4.2.2 Increasing Awareness among Customers about Cosmetic Procedures

      3. 4.2.3 Availability of Technologically Advanced & User-friendly Products

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Safety Regulations for Aesthetic Procedures

      2. 4.3.2 Risk of Side Effects

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Botulinum Toxin

      2. 5.1.2 Dermal Filler

        1. Absorbable Dermal Filler

        2. Non-absorbable Dermal Filler

      3. 5.1.3 Chemical Peel

      4. 5.1.4 Microdermabrasion

    2. 5.2 By End User

      1. 5.2.1 Aesthetic Clinics

      2. 5.2.2 Hospitals

      3. 5.2.3 Other End Users


    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc. (AlLergan Plc)

      2. 6.1.2 Bioxis Pharmaceuticals

      3. 6.1.3 Dermaceutic Laboratoire

      4. 6.1.4 Ipsen Pharma

      5. 6.1.5 Sinclair Pharma PLC

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Galderma(Nestle Skin Health)

      8. 6.1.8 Merz Pharma GmbH & Co. KGaA

      9. 6.1.9 Laboratoires Filorga

      10. 6.1.10 Teoxane Laboratories

      11. 6.1.11 Laboratories Vivacy

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The France Aesthetic Medicine Market market is studied from 2018 - 2026.

The France Aesthetic Medicine Market is growing at a CAGR of 8.58% over the next 5 years.

AbbVie Inc. (AlLergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Johnson & Johnson are the major companies operating in France Aesthetic Medicine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!